
At the 44th National Association of Pediatric Nurse Practitioners Conference, data was presented on how to diagnose and treat polycystic ovarian syndrome in adolescent patients.

At the 44th National Association of Pediatric Nurse Practitioners Conference, data was presented on how to diagnose and treat polycystic ovarian syndrome in adolescent patients.

What questions should PNPs consider related to women’s health?

After observing an increase in the rate of syphilis cases, the Cleveland Clinic Ob/Gyn & Women’s Health Institute has partnered with the Center for Pediatric Infectious Diseases to evaluate the effectiveness of current testing strategies.

Bacterial vaginosis during pregnancy may lead to increased risks for preterm birth, preterm delivery, and spontaneous abortion, according to new research in the Archives of Gynecology and Obstetrics.

Racial and ethnic disparities in adverse perinatal outcomes were significantly greater among women who used medically assisted reproduction (MAR) than those who conceived spontaneously, according to a study published in the journal Pediatrics.

In a recent presentation at at the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Conference, Carri Holton, MSN, WHNP, discussed gynecological complications that adolescents may face and offered practical treatment options.

In a presentation at the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Conference, Katie Huffling DNP, RN, CNM, FAAN, explained how different cases of environmental exposure are impacting women’s health.

If approved, ibrexafungerp would be the first and only approved therapy for both the treatment of vulvovaginal candidiasis (VVC) and the prevention of recurrent vulvovaginal candidiasis (RVVC).

What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.

Perrigo’s HRA Pharma has submitted an application to the US Food and Drug Administration (FDA) for possible future approval of the first-ever OTC birth control pill.

Prenatal exposure to the antiseizure medications topiramate and valproate may cause a significantly increased risk of neurodevelopmental disorders in offspring, according to a cohort study in JAMA Neurology.

A retrospective study found that postmenarchal women with a renal anomaly were also at risk of having a Müllerian anomaly.

The increase was highest for Hispanic and non-Hispanic Black Women.

With the Supreme Court's overturning of Roe v Wade eliminating the constitutional right to an abortion, there are questions about its impact on fertility care.

Understanding signs, symptoms helps determine the best treatment regimen.

The American Medical Association is urging the FDA to approve OTC access to oral contraceptives.

Period poverty isn’t just an issue in third-world countries or among low-income women. Across the United States, women of all ages still struggle to afford menstrual products.

Vaginal yeast infections were successfully treated with berberine, a biologically active herbal alkaloid, according to a study published in Frontiers in Pharmacology.

A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.

Postpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.

A recent study showed that patients with atopic dermatitis have a higher prevalence of infertility, highlighting the need for clinicians to be wary of this increased risk and improve the care and management of this patient population.

Research from the Developing Brain Institute found maternal psychological distress during the COVID-19 pandemic had disrupted critical processes of fetal brain development.

Currently approved for the treatment of vulvovaginal candidiasis, and if the sNDA is approved, ibrexafungerp would be the first and only oral non-azole medication for the prevention of recurrent VVC.

The FDA recently announced the acceptance of a supplemental New Drug Application for relugolix 40 mg, estradiol 1 mg, and norethindrone acetate .5 mg in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.

Offering an inclusive, safe space along with the best care for transgender and nonbinary adolescent patients is more important than ever.